- Joined
- Jan 16, 2021
- Messages
- 729
Sogroya is a new long-acting human growth hormone therapy that is administered once a week via injection under the skin
Link
Link
Novo Nordisk’s Sogroya moves closer towards EU approval - PharmaTimes
CHMP recommended marketing authorisation for human growth hormone therapy
www.pharmatimes.com